| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.2M | -93.8% |
| Cost of Revenue | $886K | -95.7% |
| Gross Profit | $1.3M | -74.0% |
| R&D Expense | $313K | -8.8% |
| SG&A Expense | $6.2M | -45.8% |
| Operating Income | -$33.9M | -38.9% |
| Interest Expense | $77K | — |
| Pre-tax Income | -$34.2M | +0.5% |
| Net Income | -$33.0M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Short-term Investments | $1K | -99.9% |
| Accounts Receivable | $2.1M | -63.4% |
| Current Assets | $20.7M | -62.0% |
| Total Assets | $25.9M | -57.5% |
| Current Liabilities | $13.1M | -26.0% |
| Total Liabilities | $13.3M | -28.2% |
| Stockholders' Equity | $14.5M | -67.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Capital Expenditures | $34K | -48.1% |
| +2.1% |
| EPS (Basic) | -$1.57 | +31.1% |
| EPS (Diluted) | -$1.57 | +31.1% |